Guidance Issued for Preventing Cutaneous SCC in Solid Organ Recipients
For five of six actinic damage and skin cancer index stages, consensus-based recommendations developed
For five of six actinic damage and skin cancer index stages, consensus-based recommendations developed
AML survivors treated with blood or marrow transplantation have a greater risk of grade 3 or higher chronic health conditions, according to a survey that compared the long-term outcomes between survivors and their healthy siblings.
Data from the CIBMTR demonstrate a need to develop return-to-work interventions for patients who have undergone HCT as treatment of malignant, as well as nonmalignant, conditions.
Researchers explored the effect of using antibiotics commonly used to treat neutropenic fever on likelihood of aGVHD developing in younger patients who underwent HCT for acute leukemia.
Using a computational approach, researchers detected the effect of dietary changes and antibacterial therapies on gut microbiota of patients who had undergone allo-HSCT, which may be associated with adverse events such as GVHD.
This retrospective analysis compared auto-HSCT and allo-HSCT with tandem auto-HSCT and auto-allo-HSCT to determine which strategy provided better PFS and OS for patients with multiple myeloma.
In this study, complete viral clearance was achieved with cryopreserved matched VST developed against CMV, EBV, or ADV in patients who developed the viral infection after allogeneic stem cell transplantation.
Researchers sought to determine the opportunity costs for patients and caregivers in the inpatient vs outpatient settings for patients undergoing ASCT.
In this systematic review, researchers analyzed the cost effectiveness of various treatments and treatment lines for multiple myeloma.
A retrospective study identifies prognoses and risk factors for SCC among solid organ transplant recipients.